Literature DB >> 24421474

ISMP Adverse Drug Reactions.

.   

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Entities:  

Year:  2013        PMID: 24421474      PMCID: PMC3839448          DOI: 10.1310/hpj4804-270

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  2 in total

Review 1.  Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.

Authors:  Antonio B Fernández; Richard H Karas; Alawi A Alsheikh-Ali; Paul D Thompson
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

2.  Dermatomyositis with lung involvement in a patient treated with simvastatin.

Authors:  C Hill; C Zeitz; B Kirkham
Journal:  Aust N Z J Med       Date:  1995-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.